GlassScriptPhysician profile
Cynthia J Mingea
NPI 1497731871
$2,314.15
in general payments reported to CMS, 2019-2025
25 companies · $19.53 in 2025
The $19.53 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,077 · 2020: $371 · 2021: $231 · 2022: $487 · 2023: $99.32 · 2024: $28.48 · 2025: $19.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $413.65 | 2019-2020 | |
| Abbvie INC. | $230.93 | 2019-2023 | |
| Hologic Sales and Service, LLC | $202.60 | 2019-2023 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Roche Diagnostics Corporation | $188.11 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $186.67 | 2022-2023 | |
| Coopersurgical, INC. | $141.57 | 2022-2023 | Paragard T 380a |
| Therapeuticsmd, INC. | $137.36 | 2019-2022 | |
| Evofem Biosciences, INC. | $125.18 | 2021-2022 | |
| Gilead Sciences, INC. | $120.72 | 2019 | |
| Exeltis, USA INC. | $103.78 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $67.78 | 2019-2021 | |
| Lupin INC. | $58.49 | 2019-2020 | |
| Organon LLC | $55.42 | 2022-2024 | |
| Vertical Pharmaceuticals, LLC | $40.44 | 2019 | |
| Pfizer INC. | $35.94 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $35.51 | 2019 | |
| Aspira Women'S Health INC | $28.98 | 2019 | |
| Allergan, INC. | $27.78 | 2019 | |
| Biogen, INC. | $19.53 | 2025 | Zurzuvae |
| Scynexis, INC. | $18.42 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.23 | 2019 | |
| Dysis Medical, INC. | $15.58 | 2021 | |
| Amag Pharmaceuticals, INC. | $15.27 | 2019 | |
| Avion Pharmaceuticals | $15.16 | 2019 | |
| Covidien LP | $12.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Mingea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.